Healthcare Archives - Universal Group Of Institutions
India's No.1 PU & Degree With Integrated IAS & IPS(UPSC/PSC) Training College.

*** Admissions are open for 2025-26. Courses offered - PUC (Commerce & Arts), BSc (Environmental Science), BA, B.Com, MA ***

Tag

img
04Feb 2025

World Cancer Day: Awareness, Treatment Advances, and Hope

Why the news? World Cancer Day, observed annually on February 4, focuses on raising global awareness about cancer, promoting prevention, and highlighting recent breakthroughs in diagnosis and treatment to improve survival rates and quality of life for patients. Awareness and Prevention: Healthy Lifestyle: Balanced diet, regular exercise, avoiding tobacco and alcohol. Vaccination: Protect against HPV …

Read More
13Dec 2024

Gene Therapy Successfully Treats Haemophilia A in India

Why in the news? Indian scientists have made significant advancements in using gene therapy to treat Haemophilia A, a rare blood disorder. This breakthrough offers long-term relief by addressing the genetic cause, improving quality of life for affected individuals. About Gene Therapy Breakthrough for Haemophilia A in India: Indian scientists have achieved significant progress in …

Read More
07Dec 2024

India’s Accelerated Fight Against Tuberculosis: A Unified Approach

Syllabus: GS-2: Health , Government Policies & Interventions , Important International Institutions Why in the news? India has launched a transformative 100-day campaign across 347 high-burden districts to eliminate tuberculosis (TB). This initiative aims to accelerate early diagnosis, treatment, and nutritional support, reflecting the country’s commitment to achieving the 2025 TB elimination target under Prime …

Read More
26Oct 2024

Semaglutide May Reduce Alzheimer’s Risk in Diabetics

Why in the news? A new study suggests that semaglutide, a drug for type 2 diabetes and weight loss, may significantly reduce Alzheimer’s risk. This potential breakthrough offers a novel approach to dementia prevention alongside diabetes management, especially for high-risk populations. Study Overview and Findings: Semaglutide, the active ingredient in popular drugs for type 2 …

Read More